Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 16, 2019
[ Tue, Apr 16th 2019
] - WOPRAI
[ Tue, Apr 16th 2019
] - WOPRAI
[ Tue, Apr 16th 2019
] - WOPRAI
[ Tue, Apr 16th 2019
] - WOPRAI
Mon, April 15, 2019
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
[ Mon, Apr 15th 2019
] - WOPRAI
Sumant Kulkarni Maintained (BHVN) at Strong Buy with Increased Target to $89 on, Apr 15th, 2019
Sumant Kulkarni of Canaccord Genuity, Maintained "Biohaven Ltd." (BHVN) at Strong Buy with Increased Target from $46 to $89 on, Apr 15th, 2019.
Sumant has made no other calls on BHVN in the last 4 months.
There is 1 other peer that has a rating on BHVN. Out of the 1 peers that are also analyzing BHVN, all agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold on, Tuesday, April 9th, 2019
